Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component (Q37148370)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2009

Language	Label	Description	Also known as
English	Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component	scientific article published on February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

Angela Dispenzieri

4

object named as

Angela Dispenzieri

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

13

object named as

Robert A Kyle

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

2

object named as

Martha Q Lacy

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Stephen J. Russell

9

object named as

Stephen J Russell

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

S. Vincent Rajkumar

14

object named as

S Vincent Rajkumar

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

object named as

Morie A Gertz

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Suzanne R Hayman

8

object named as

Suzanne R Hayman

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Steven R Zeldenrust

3

object named as

Steven R Zeldenrust

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

object named as

John A Lust

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Francis K Buadi

10

object named as

Francis K Buadi

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

7

object named as

Shaji Kumar

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Thomas E. Witzig

6

object named as

Thomas E Witzig

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Philip R. Greipp

15

object named as

Philip R Greipp

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Susan Michelle Geyer

11

object named as

Susan M Geyer

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael P Kline

16

object named as

Michael P Kline

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

17

object named as

Yuning Xiong

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Laurie L Moon-Tasson

18

object named as

Laurie L Moon-Tasson

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Megan E Campbell

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kathleen A Donovan

19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

84

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

114-122

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Treatment of multiple myeloma: an emphasis on new developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

The paradox of response and survival in cancer therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

The role of interleukin-1 beta in the pathogenesis of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Biologic basis for interleukin-1 in disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

6 September 2017

Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

14 September 2017

Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

29 September 2017

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

29 September 2017

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

29 September 2017

Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

29 September 2017

Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

27 June 2018

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

27 June 2018

Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

27 June 2018

Thalidomide as initial therapy for early-stage myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

3 September 2018

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2664581

4 December 2018

Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic features of asymptomatic multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of disease progression in asymptomatic multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. II

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19181644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4065/84.2.114

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37148370&oldid=2245285406"